← Leaderboards
Michael A Gimbrone
Brigham And Women'S Hospital
$16,320,214
Attributed
$18,117,648
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–19$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$52,719,474 · 8
By mechanism
P01$21,982,997 · 2
P50$15,213,048 · 3
T32$12,165,714 · 1
R37$1,777,041 · 1
R01$1,580,674 · 1
Top collaborators
- Richard N Mitchell7 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Mark W Feinberg$27,862,974
- Robert Sackstein$20,708,410
- Guo-Ping Shi$19,551,120
- Merry L Lindsey$12,766,097
- Jose R Romero$3,042,294
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsVascular EndotheliumGene ExpressionInjuryKidneyLungCell Adhesion MoleculesAtherosclerosisCell Cell InteractionInflammationCytokineTissue /Cell CultureLaboratory MouseAtherosclerotic PlaqueBiomechanicsHuman TissueHemodynamicsFunctional DisorderGenesEndothelial CellsEventGeneticCell PhysiologyAnti-Inflammatory Agents
Grant awards (56)
Vascular, Pulmonary and Renal Injury$294,638
T32 · FY2019 · HL
Vascular, Pulmonary and Renal Injury$860,501
T32 · FY2018 · HL
Vascular, Pulmonary and Renal Injury$821,426
T32 · FY2017 · HL
Vascular, Pulmonary and Renal Injury$8,191
T32 · FY2017 · HL
Vascular, Pulmonary and Renal Injury$4,922
T32 · FY2017 · HL
Vascular, Pulmonary and Renal Injury$815,633
T32 · FY2016 · HL
Vascular, Pulmonary and Renal Injury$789,558
T32 · FY2015 · HL · contact PI
Vascular, Pulmonary and Renal Injury$646,155
T32 · FY2014 · HL · contact PI
PROGERIN ENDOTHELIAL DYSFUNCTION AND VASCULAR DISEASE$317,256
R01 · FY2014 · AG · contact PI
Vascular, Pulmonary and Renal Injury$733,947
T32 · FY2013 · HL · contact PI
PROGERIN ENDOTHELIAL DYSFUNCTION AND VASCULAR DISEASE$299,806
R01 · FY2013 · AG · contact PI
Vascular, Pulmonary and Renal Injury$733,947
T32 · FY2012 · HL · contact PI
PROGERIN ENDOTHELIAL DYSFUNCTION AND VASCULAR DISEASE$317,256
R01 · FY2012 · AG · contact PI
Vascular, Pulmonary and Renal Injury$642,777
T32 · FY2011 · HL · contact PI
PROGERIN ENDOTHELIAL DYSFUNCTION AND VASCULAR DISEASE$317,185
R01 · FY2011 · AG · contact PI
Vascular, Pulmonary and Renal Injury$706,035
T32 · FY2010 · HL · contact PI
PROGERIN ENDOTHELIAL DYSFUNCTION AND VASCULAR DISEASE$329,171
R01 · FY2010 · AG · contact PI
VASCULAR, PULMONARY AND RENAL INJURY$420,133
T32 · FY2009 · HL · contact PI
VASCULAR, PULMONARY AND RENAL INJURY$620,017
T32 · FY2008 · HL · contact PI
PATHOPHYSIOLOGY OF THE ENDOTHELIUM$2,498,374
P01 · FY2007 · HL · contact PI
VASCULAR, PULMONARY AND RENAL INJURY$668,642
T32 · FY2007 · HL · contact PI
E-SELECTIN-DEPENDENT ENDOTHELIAL PHENOTYPIC MODULATION$475,020
P01 · FY2007 · HL · contact PI
PATHOPHYSIOLOGY OF THE ENDOTHELIUM$2,503,300
P01 · FY2006 · HL · contact PI
CRITICAL TRANSITIONS IN ATHEROGENESIS$1,931,617
P50 · FY2006 · HL · contact PI
VASCULAR, PULMONARY AND RENAL INJURY$510,901
T32 · FY2006 · HL · contact PI
E-SELECTIN-DEPENDENT ENDOTHELIAL PHENOTYPIC MODULATION$260,824
P01 · FY2006 · HL · contact PI
HEMODYNAMICS AND MOLECULAR GENETIC RISK FACTORS IN ATHEROSCLEROSIS$48,533
P50 · FY2006 · HL · contact PI
PATHOPHYSIOLOGY OF THE ENDOTHELIUM$2,493,178
P01 · FY2005 · HL
CRITICAL TRANSITIONS IN ATHEROGENESIS$1,921,660
P50 · FY2005 · HL
VASCULAR, PULMONARY AND RENAL INJURY$665,480
T32 · FY2005 · HL
HEMODYNAMICS AND MOLECULAR GENETIC RISK FACTORS IN ATHEROSCLEROSIS$396,849
P50 · FY2005 · HL
Administrative$280,978
P50 · FY2005 · HL
E-SELECTIN-DEPENDENT ENDOTHELIAL PHENOTYPIC MODULATION$254,550
P01 · FY2005 · HL
PATHOPHYSIOLOGY OF THE ENDOTHELIUM$2,461,590
P01 · FY2004 · HL
CRITICAL TRANSITIONS IN ATHEROGENESIS$2,229,924
P50 · FY2004 · HL
Vascular, Pulmonary and Renal Injury$493,762
T32 · FY2004 · HL
PATHOPHYSIOLOGY OF THE ENDOTHELIUM$2,399,202
P01 · FY2003 · HL
CRITICAL TRANSITIONS IN ATHEROGENESIS$2,159,296
P50 · FY2003 · HL
VASCULAR, PULMONARY AND RENAL INJURY$670,665
T32 · FY2003 · HL
ENDOTHELIAL GENE REGULATION BY BIOMECHANICAL FORCES$460,365
R37 · FY2003 · HL
PATHOPHYSIOLOGY OF THE ENDOTHELIUM$2,798,945
P01 · FY2002 · HL
CRITICAL TRANSITIONS IN ATHEROGENESIS$2,098,013
P50 · FY2002 · HL
VASCULAR, PULMONARY AND RENAL INJURY$594,110
T32 · FY2002 · HL
ENDOTHELIAL GENE REGULATION BY BIOMECHANICAL FORCES$449,417
R37 · FY2002 · HL
E-SELECTIN DEPENDENT COMMUNICATION IN INFLAMMATION$68,666
P01 · FY2002 · HL
PATHOPHYSIOLOGY OF THE ENDOTHELIUM$2,724,744
P01 · FY2001 · HL
CRITICAL TRANSITIONS IN ATHEROGENESIS$1,892,100
P50 · FY2001 · HL
VASCULAR, PULMONARY AND RENAL INJURY$464,274
T32 · FY2001 · HL
ENDOTHELIAL GENE REGULATION BY BIOMECHANICAL FORCES$438,790
R37 · FY2001 · HL
E-SELECTIN DEPENDENT COMMUNICATION IN INFLAMMATION$68,666
P01 · FY2001 · HL
HEMODYNAMICS AND MOLECULAR GENETIC RISK FACTORS IN ATHEROSCLEROSIS$48,533
P50 · FY2001 · HL
PATHOPHYSIOLOGY OF THE ENDOTHELIUM$2,652,701
P01 · FY2000 · HL
CRITICAL TRANSITIONS IN ATHEROGENESIS$1,837,182
P50 · FY2000 · HL
ENDOTHELIAL GENE REGULATION BY BIOMECHANICAL FORCES$428,469
R37 · FY2000 · HL
HEMODYNAMICS AND MOLECULAR GENETIC RISK FACTORS IN ATHEROSCLEROSIS$368,363
P50 · FY2000 · HL
E-SELECTIN DEPENDENT COMMUNICATION IN INFLAMMATION$323,237
P01 · FY2000 · HL